From:  Genetic basis for skeletal new bone formation

Overview of several genes related in the Wnt signaling pathway associated with diseases marked by bone overgrowth

Protein activityGeneChrProtein function in Wnt signalingDisease (manifestation)References
Transmembrane co-receptorsLRP511Co-receptor that works with frizzled protein in the membraneEndosteal hyperostosis (Worth disease; OMIM#144750) and steosclerosis (high bone mass)[75, 102]
LRP411Related to LRP5/6 in modulation of Wnt/β-catenin pathway. Bind to SOSTDC1, also known as WISE, a family of Wnt antagonists [103] Sclerosteosis type 2 (OMIM#614305)[97]
InhibitorsDKK110Inhibitor of Wnt signaling pathway

DISH (OMIM#106400), OPLL (OMIM%602475), AS (OMIM#106300), and OYL

(low levels of DKK1 in humans)

[104]
SOST17SOST by osteocytes is responsible for inhibiting bone formationSclerosteosis type 1 (OMIM#269500), Van Buchem disease (OMIM#239100), and Craniodiaphyseal dysplasia (OMIM#122860; high bone mass)[94, 96, 105]
SFRP47Secreted protein which binds to Wnt ligands and inhibits Wnt signalingPyle’s disease (OMIM#265900)[106108]
WTX/AMER1XEncodes an intracellular repressor of canonical Wnt signalingOsteopathia striata (OMIM#300373; high bone mass)[91]

Chr: chromosome; SOSTDC1: SOST domain-containing protein 1; DISH: diffuse idiopathic skeletal hyperostosis; OPLL: ossification of the posterior longitudinal ligament; AS: ankylosing spondylitis; OYL: ossification of yellow ligament